Literature DB >> 10995784

Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.

W J Murphy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10995784      PMCID： PMC381400          DOI： 10.1172/JCI11088

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.

Authors:  A Shustov; I Luzina; P Nguyen; J C Papadimitriou; B Handwerger; K B Elkon; C S Via
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  How do cytotoxic lymphocytes kill their targets?

Authors:  S Shresta; C T Pham; D A Thomas; T A Graubert; T J Ley
Journal:  Curr Opin Immunol       Date:  1998-10       Impact factor: 7.486

3.  Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice.

Authors:  S Sambhara; I Switzer; A Kurichh; R Miranda; L Urbanczyk; O James; B Underdown; M Klein; D Burt
Journal:  Cell Immunol       Date:  1998-07-10       Impact factor: 4.868

4.  Perforin protects against autoimmunity in lupus-prone mice.

Authors:  S L Peng; J Moslehi; M E Robert; J Craft
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

5.  Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.

Authors:  T Wekerle; J Kurtz; H Ito; J V Ronquillo; V Dong; G Zhao; J Shaffer; M H Sayegh; M Sykes
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 6.  New strategies for preventing graft-versus-host disease.

Authors:  W J Murphy; B R Blazar
Journal:  Curr Opin Immunol       Date:  1999-10       Impact factor: 7.486

7.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

Authors:  S E Stepp; R Dufourcq-Lagelouse; F Le Deist; S Bhawan; S Certain; P A Mathew; J I Henter; M Bennett; A Fischer; G de Saint Basile; V Kumar
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

8.  Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice.

Authors:  H G Zhang; M Fleck; E R Kern; D Liu; Y Wang; H C Hsu; P Yang; Z Wang; D T Curiel; T Zhou; J D Mountz
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

9.  Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.

Authors:  A Shustov; P Nguyen; F Finkelman; K B Elkon; C S Via
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

10.  Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.

Authors:  C A Ellison; J M Fischer; K T HayGlass; J G Gartner
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422
View more
  4 in total

Review 1.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

2.  Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease.

Authors:  Juyang Kim; Sohye Park; Hyun-A Kim; Daehee Jung; Hyun Ju Kim; Hye-Jeong Choi; Hong Rae Cho; Byungsuk Kwon
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

3.  De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience.

Authors:  Yul Hee Cho; Seok Hui Kang; Yaeni Kim; Myung Hyun Lee; Gun Hee An; Byung Ha Chung; Bum Soon Choi; Chul Woo Yang; Yong-Soo Kim; Yeong Jin Choi; Cheol Whee Park
Journal:  Kidney Res Clin Pract       Date:  2013-08-30

4.  A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.

Authors:  Lijun Shen; Ying Zhu; Lianhua Han; Yuyu Wang; Tianming Yan; Yong Kong; Shitao Zou; Yuhua Qiu; Yan Xu
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.